fda bpc-157 approval status Status: Is It Approved for Human Use? BPC-157 Legal Status: FDA Regulations

Bremelanotide can cause significant nausea (reported in up to 40% of users in clinical trials), increased blood pressure, and flushing

That is the evidence gap, stated plainly: the mechanism is well-motivated and the preclinical signal is consistent, but no human study has confirmed that any of it translates to people, at any dose, by any route

NAD+ is essential in metabolic function, promoting athletic function, boosting brain repair, and function

Is there human evidence specifically for the injectable version

While it may indirectly aid fat loss by supporting recovery and digestive function, theres limited direct clinical evidence linking BPC-157 to significant fat reduction

But each test serves a purpose